We work with key partners to advance our understanding of how the CNS will impact and be effected by cure strategies. Projects are managed by a leadership team comprised of Principal Investigators at the U.S. Military HIV Research Program and Yale University.
Leadership
Jintanat Ananworanich, MD, PhD
Dr. Ananworanich is the Associate Director for Therapeutics Research at the U.S. Military HIV Research Program (MHRP). Over the past decade she has led more than 80 studies including the Staccato treatment interruption study and the NIAID-funded study, PREDICT, on when to start antiretroviral therapy in HIV-infected children. Prior to assuming her current role at MHRP, Dr. Ananworanich served as the Chief of SEARCH in Thailand and Deputy Director of Scientific Affairs at the HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT) at the Thai Red Cross in Bangkok. She has served as a member of the Paediatric European Network for Treatment of AIDS (PENTA) steering committee since 2009, and is a member of the ACTG and the IMPAACT HIV Cure committees, and co-chairs the acute HIV infection working group of the ACTG and the clinical research working group of the Forum Cure Project. Dr. Ananworanich received her medical degree from Prince of Songkhla Medical School in Thailand, and her PhD in Medicine from the University of Amsterdam. She is board certified in pediatrics, allergy and immunology, and clinical and laboratory immunology.
Dr. Ananworanich is the Associate Director for Therapeutics Research at the U.S. Military HIV Research Program (MHRP). Over the past decade she has led more than 80 studies including the Staccato treatment interruption study and the NIAID-funded study, PREDICT, on when to start antiretroviral therapy in HIV-infected children. Prior to assuming her current role at MHRP, Dr. Ananworanich served as the Chief of SEARCH in Thailand and Deputy Director of Scientific Affairs at the HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT) at the Thai Red Cross in Bangkok. She has served as a member of the Paediatric European Network for Treatment of AIDS (PENTA) steering committee since 2009, and is a member of the ACTG and the IMPAACT HIV Cure committees, and co-chairs the acute HIV infection working group of the ACTG and the clinical research working group of the Forum Cure Project. Dr. Ananworanich received her medical degree from Prince of Songkhla Medical School in Thailand, and her PhD in Medicine from the University of Amsterdam. She is board certified in pediatrics, allergy and immunology, and clinical and laboratory immunology.
Serena Spudich, MD
Dr. Spudich is a neurologist whose clinical and translational research is focused on the pathogenesis of HIV in the nervous system, in particular the impact of acute HIV infection and early treatment on the central nervous system and the establishment of persistent CNS reservoirs for HIV. Dr. Spudich graduated from medical school at the University of California, San Francisco in 1997, then pursued residency training at the University of Washington in Internal Medicine and at the Massachusetts General Hospital/Brigham and Women’s Hospital combined program in Neurology. She returned to UCSF in 2003 as a fellow in NeuroHIV to work with Dr. Richard Price, remaining at UCSF until moving to Yale University in 2010 where she is currently Professor of Neurology. She is active in the AIDS Clinical Trials Group, recently serving as Chair of the Neurology Collaborative Science Group and as a member of the HIV Cure committee. She has collaborated with the co-directors and other INHCC investigators in SEARCH-based studies since 2010. In addition to her research, Dr. Spudich cares for HIV-infected patients with neurological disorders at the Nathan Smith HIV Clinic at Yale.
Dr. Spudich is a neurologist whose clinical and translational research is focused on the pathogenesis of HIV in the nervous system, in particular the impact of acute HIV infection and early treatment on the central nervous system and the establishment of persistent CNS reservoirs for HIV. Dr. Spudich graduated from medical school at the University of California, San Francisco in 1997, then pursued residency training at the University of Washington in Internal Medicine and at the Massachusetts General Hospital/Brigham and Women’s Hospital combined program in Neurology. She returned to UCSF in 2003 as a fellow in NeuroHIV to work with Dr. Richard Price, remaining at UCSF until moving to Yale University in 2010 where she is currently Professor of Neurology. She is active in the AIDS Clinical Trials Group, recently serving as Chair of the Neurology Collaborative Science Group and as a member of the HIV Cure committee. She has collaborated with the co-directors and other INHCC investigators in SEARCH-based studies since 2010. In addition to her research, Dr. Spudich cares for HIV-infected patients with neurological disorders at the Nathan Smith HIV Clinic at Yale.
